PHATHOM PHARMACEUTICALS INC
PHATNASDAQ🏆 #2858 by market capUS Equity
$6.28▲ $0.28 (+4.75%)
Market closed · at closeTrack PHAT
Get earnings, price moves & breaking news on Telegram
24h▲ 4.8%
7d▼ 10.3%
14d▼ 16.3%
30d▼ 14.7%
ytd▼ 62.2%
1y▼ 53.7%
🏦Market Cap
$508M
Small Cap
📈Revenue Growth (YoY)
216.9%
High Growth
📊Gross Margin
82.9%
High
💵FCF Margin
-15.3%
Thin
⚖️P/S Ratio
2.1x
Cheap
Otter Score
76
Strong
Trading Snapshot
- Day Range
- $5.87 – $6.43
- 52-Week Range
- $5.01 – $18.31
- Volume (shares)
- 188,878
- Avg Volume (shares)
- —
- Shares Outstanding
- 80.9M
- Next Earnings
- —
Fundamentals Snapshot
- Annual Revenue
- $175M
- Last Q Revenue
- $74M
- P/E Ratio
- -4.8
- P/S Ratio
- 2.1x
- EPS (TTM)
- $-1.18
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +3.9%
PHATHOM PHARMACEUTICALS INC
PHATFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$175M▲ +216.9% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
87.1%▲ +1.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$160M▼ −42.3% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$167M▼ −37.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
73.8M▲ +3.9% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$82M▼ −$177M YoY
StockOtter · stockotter.spaceAbout PHATHOM PHARMACEUTICALS INC
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company is headquartered in Florham Park, New Jersey.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Strong
76/100
Analyst data unavailable.
Latest News & Updates
News unavailable.